BioMarin Pharmaceutical (BMRN) EV/EBITDA US GAAP (year values)

2021 2022 2022 2023   LTM ?
EV/EBITDA ? 337.7 114.5 70.9 58.6   0.13
Changes by years, y/y, % -112% -100% -38% -17%    

BioMarin Pharmaceutical. EV/EBITDA

BioMarin Pharmaceutical. EV/EBITDA, changes, %

BioMarin Pharmaceutical (BMRN) EV/EBITDA US GAAP (quarter values)

2024Q1 2024Q1 2024Q2 2024Q3 2024Q3   LTM ?
EV/EBITDA ? 58.9 48.3 36.8 -2.82 25.7   0.13
Changes by years, y/y, % -38% -49% -53% -104% -61%    
Changes by quarters, q/q, % -5% -18% -24% -108% -1 011%    

BioMarin Pharmaceutical. EV/EBITDA

BioMarin Pharmaceutical. EV/EBITDA, changes, y/y, %

BioMarin Pharmaceutical. EV/EBITDA, changes, q/q, %